Previous 10 |
biote Corp. (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has appointed Samar Kamdar as its Chief Financial Officer. Mr. Kamdar will oversee Biot...
Biote today issued a correction to operating loss and net income for the three and six month periods ended June 30, 2022 in the press release titled “Biote Reports Second Quarter 2022 Financial Results,” issued on August 9, 2022. The other financial results reported in...
BIOTE press release ( OTCPK:BTMD ): Q2 net income of $49.7M in the quarter, a 409% increase Y/Y. Revenue of $41.4M (+19.0% Y/Y) beats by $0.9M . Adjusted EBITDA of $13.1M, a 21% increase Y/Y. Management maintains its full year 2022 revenue guidance of $160-166...
Company generates accelerated Revenue, net income and adjusted EBITDA growth, and raises 2022 adjusted EBITDA guidance *Revised Dial-in Information for the Conference Call* Biote , a high growth, differentiated medical practice-building business within the ho...
biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, will report its financial results for the second quarter ended June 30, 2022, after market close on Tuesday, August...
biote (NASDAQ:BTMD) on Thursday announced the appointment of Ross W. McQuivey, M.D., as its chief medical officer, effective June 10, 2022. Prior to joining Biote, McQuivey served as CMO of Laborie Medical Technologies and has more than 20 years of medical and scientific l...
Innovative physician leader brings over 20 years of experience to Biote’s executive team biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, today a...
Gainers: Evoke Pharma EVOK +52%. Zynerba Pharmaceuticals (ZYNE) +18%. LifeMD (LFMD) +13%. Vivos Therapeutics (VVOS) +12%. ACADIA Pharmaceuticals ACAD +11%. Losers: 180 Life Sciences (ATNF) -31%. Belite Bio (BLTE) -19%. VectivBio VECT -14%...
Gainers: Revlon (REV) +98%. biote (BTMD) +61%. Cepton (CPTN) +40%. Alpha Teknova (TKNO) +23%. New Oriental Education & Technology (EDU) +23%. Owlet (OWLT) +21%. Belite Bio (BLTE) +21%. Kaival Brands Innovations Group (KAVL) +20%. iQIYI (IQ) +17%. NIO (NIO) +16%. Redbox Entertainment (RDBX...
News, Short Squeeze, Breakout and More Instantly...
2024-07-06 18:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-26 20:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has signed a binding term sheet with Marci M. Donovitz...